Asia
Aspen Pharmacare Holdings, a South African generic drug company, plans to establish partnerships to build its China drug portfolio, according to management.
Inovelon will be presented at the 71st AES Annual Meeting to be held from December 1 to 5, 2017 in Washington D.C. in the United States.
The funding was led by China Reform Holdings and joined by ChinaEquity Group and several unnamed investors.
Immunochina raised $7.5M to support clinical trials of its CAR-T product for lymphoma.
In the latest joint effort, Lee’s Pharm will pair its PD-L1 candidate with icaritin.
Since taking over at Teva earlier this fall, Kare Schultz has been swiftly moving to shore up the finances and pay down the massive debts of the beleaguered pharmaceutical company.
Share prices for Protalix are up more than 3 percent this morning after the company reported positive results from its Phase I/II open label extension trial of pegunigalsidase alfa, PRX-102, for the treatment of Fabry disease.
News of the layoffs comes hard on the heels of the company’s credit rating having been cut to junk status by Fitch Rating.
A look at the 19 spine-related medical devices the FDA cleared in October.
Zensun Science & Technology raised $76M from a group of investors led by SDIC Venture Capital Management, which contributed half of the funding itself.
PRESS RELEASES